C
8158
vs
H
Hang Seng (Hong Kong)
Over the past 12 months, China Regenerative Medicine International Ltd has underperformed Hang Seng (Hong Kong), delivering a return of -15% compared to the Hang Seng (Hong Kong)'s +21% growth.
Stocks Performance
8158 vs Hang Seng (Hong Kong)
Performance Gap
8158 vs Hang Seng (Hong Kong)
Performance By Year
8158 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
China Regenerative Medicine International Ltd
Glance View
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development of medical and healthcare products. Along with subsidiaries, the Company operates its business through four segments. The Medical Equipment segment is involved in trading of medical equipments. The Tissue Engineering segment is involved in production and sale of tissue engineering products. The Cosmetic and Others segment is involved in production and sales of cosmetic, healthcare and other products. The Stem Cell segment is involved in research of cellular and stem cell therapy, sales and distribution of stem cell medical equipment, as well as the provision of other services.
